查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1847890

細菌和病毒檢體採集市場（按檢體類型、產品、技術、最終用戶和分銷管道分類）—2025-2032年全球預測

Bacterial & Viral Specimen Collection Market by Specimen Type, Product, Technology, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，細菌和病毒檢體採集市場將成長至 503.5 億美元，複合年成長率為 10.22%。

主要市場統計數據
基準年 2024 231億美元
預計年份：2025年 254.5億美元
預測年份：2032年 503.5億美元
複合年成長率 (%) 10.22%

了解在不斷變化的臨床環境中，檢體採集檢體和營運彈性如何成為診斷準確性和公共衛生緊急準備的關鍵所在。

細菌和病毒檢檢體採集是現代臨床診斷、感染疾病監測和治療監測的基石。高檢體完整性可確保檢測結果的準確性，支持及時的臨床決策，並為應對新疫情的公共衛生反應奠定基礎。近年來，隨著實驗室技術的進步和臨床工作流程的演變，在日益分散的醫療環境中，能夠維持檢體完整性的採集系統的重要性日益凸顯。

隨著診斷方法的多樣化，檢體採集正從單一的物流功能轉變為端到端診斷品質的關鍵環節。臨床實驗室、醫院、門診部和診斷中心都在尋求能夠可靠支援分子檢測、培養方法和就地檢驗的系統。同時，製造商和採購團隊面臨著許多複雜的要求，包括與自動化分析儀的兼容性、運輸介質的穩定性、拭子材料的性能以及低溫運輸和環境穩定性等方面的限制。

這種做法將檢體採集置於更廣泛的診斷生態系統中，該系統優先考慮檢體品質、可追溯性和工作流程效率。以下章節將分析正在重塑產品設計、供應鏈和區域需求模式的各種因素，為理解產品開發、採購和營運韌性方面的策略選擇奠定全面基礎。

檢驗了技術、臨床和供應鏈力量融合所帶來的影響，這種融合正在重新定義人們對檢體體採集系統和診斷操作的預期。

技術創新、監管環境的改善以及醫療服務模式的演進正在改變細菌和病毒檢體採集的模式。拭子材料、運輸培養基配方以及檢體相容型採集管的進步，為在各種臨床環境中保存核酸和活體微生物創造了新的可能性。這些技術發展與自動化技術的改進相輔相成，簡化了工作流程，並降低了高通量實驗室的分析前變異性。

同時，檢測方式向照護現場（POC​​）、免下車採集點和居家採樣等場所的分散化，也帶來了新的設計要求，包括易用性、常溫下檢體穩定性以及面向非臨床用戶的詳盡操作指南。對分子診斷日益成長的依賴，推動了對能夠防止核酸分解並最大限度減少抑制性污染物的運輸培養基的需求。為此，製造商正優先考慮與診斷平台的交叉相容性，檢驗在傳統臨床樣本和新型自採集檢體中的表現。

在商業層面，隨著數位化採購管道的成熟以及經銷商拓展服務範圍，涵蓋低溫運輸物流和最後一公里履約，分銷模式正在改變。環境永續性也逐漸成為營運重點，推動著材料和包裝領域的創新。在整個價值鏈中，這些因素正在匯聚，重新定義產品藍圖、採購標準和品質保證實務。

分析近期關稅措施如何重塑檢體採集組件的採購經濟、供應鏈本地化獎勵以及供應商策略。

2025年針對特定進口醫療產品實施的新關稅，為檢體採集供應鏈和採購經濟帶來了顯著的曲折點。關稅帶來的成本壓力在那些大量依賴海外採購的組件中最為明顯，例如專用拭子纖維、聚合物採集管以及運輸培養基中使用的特殊試劑。這些成本的增加正在影響醫院、實驗室和診斷中心的採購決策，進一步加劇了營運預算和採購週期的現有壓力。

為此，相關人員採取了多種適應策略。一些製造商加快了生產能力的本地化進程，以減輕跨境課稅的影響並縮短前置作業時間。另一些製造商則透過在臨床可接受的情況下替代原料或追求設計效率來最佳化材料清單，從而降低對進口的依賴。經銷商和直銷團隊重新評估了定價模式和服務組合，以在維持終端用戶交貨時間競爭力的同時保障利潤。在臨床實驗室和大型醫院系統中，採購團隊增加了供應商多元化程度，並簽訂了長期契約，以抵禦價格波動並確保庫存緩衝。

除了直接的成本影響外，關稅也影響了戰略投資選擇。如今，在自動化基礎設施的資本投資、庫存持有政策以及供應商資格認證時間表等方面的決策，都納入了貿易政策風險評估這一新的考量。雖然這些調整在短期內增加了複雜性，但也為國內供應商和契約製造製造商擴大產能創造了機會，並為最終用戶協商整合服務協議提供了契機，從而降低檢體生命週期內的總成本影響。

將檢體類型、產品架構、技術平台、終端用戶需求和分銷管道轉化為可行的產品和商業優先事項。

對細分市場的深入理解對於使產品設計和商業策略與臨床需求保持一致至關重要。從血液、尿液和傷口採集的細菌檢體與從血液、鼻咽拭子和唾液採集的病毒檢體相比，在無菌條件、容器和運輸培養基方面有著不同的需求。每種檢體基質都存在獨特的穩定性挑戰和分析前變異性，必須針對目標診斷方法進行驗證。

產品層面的細分進一步明確了預期性能。採集試劑套件整合了多種組件，以確保採樣安全且可追溯。採集管有真空和非真空兩種形式，必須與下游自動化和離心工作流程相容。拭子設計有棉質、絨毛和泡沫等多種類型，會影響檢體的吸收和釋放動力學，進而影響分析靈敏度。轉運培養基配方分為細菌轉運培養基和病毒轉運培養基，每種培養基都經過最佳化，可在特定的溫度和時限內維持細菌活性和核酸完整性。

自動化系統可提高吞吐量並減少分析前誤差，而手動方法則可在低容量或分散式環境中保持靈活性。終端用戶細分決定了採購偏好和採購量動態。診所和診斷中心通常優先考慮經濟高效、易於使用且適用於照護現場的解決方案。醫院則要求與集中式實驗室自動化系統相容，並具備強大的可追溯性。實驗室重視批次處理的兼容性、檢驗資料和供應的連續性。分銷管道的選擇——直銷、分銷商或線上管道——決定了交貨時間、服務水準和價格透明度，並影響製造商如何建立商業夥伴關係和售後服務。

繪製出各地區的管理體制、生產能力和臨床基礎設施如何影響產品開發重點和分銷模式的圖譜。

區域動態將在產品設計、監管策略和分銷模式的優先排序中發揮關鍵作用。在美洲，強大的實驗室網路和對分子診斷的大量投資，使得高性能運輸培養基、多功能拭子和自動化相容的採血管的需求持續旺盛。大型醫院系統的採購週期通常集中化，允許數量協商，但也需要大量的檢驗資料才能確保長期合約。供應鏈韌性和國內製造業是該地區政策和私人投資的重點領域。

歐洲、中東和非洲的市場格局各不相同。歐洲部分地區的法規十分嚴格，要求提供全面的技術文件和合格評定，而其他地區則優先考慮價格和易用性，以應對診斷獲取方面更廣泛的挑戰。分銷網路也存在差異，成功往往取決於是否擁有能夠管理低溫運輸物流和監管申報的本地合作夥伴。在該地區，靈活的產品組合和在地化的培訓資源對於打入市場策略大有裨益。

亞太地區持續保持成長和創新中心的地位，大型中心實驗室迅速採用自動化技術，照護現場和區域檢測基礎設施也不斷擴展。該地區部分地區的生產能力為全球供應鏈提供支持，同時多個市場的監管管道日益精簡，從而加快了產品上市速度。在整個全部區域，與診斷平台的互通性、在當地氣候條件下有效的穩定性以及符合當地文化的採集方法都是產品開發和開發方法中的優先事項。

識別領導企業為贏得檢體採集市場所採取的策略性舉措，這些舉措結合了產品創新、製造敏捷性和可服務的商業化。

檢體採集領域的領導者和創新挑戰者正朝著一系列平行策略重點邁進，以期在整個診斷價值鏈中獲取價值。垂直整合仍然是一種極具吸引力的策略。能夠掌控上游原料採購、內部培養基配方和委託製造的公司，可以享受更嚴格的品管和更短的前置作業時間。在無法實現垂直整合的情況下，與試劑和診斷平台供應商建立策略聯盟和共同開發契約，可以統一資格認證要求，並加快檢驗流程。

研發投入主要集中在拭子材料科學、常溫運輸培養基的穩定化學配方、兼顧自動化相容性和生物安全性的管路設計。一些市場參與企業正優先考慮跨多個地區的監管申報，將臨床性能數據與完善的生產品質系統相結合，以推動產品在醫院和參考實驗室的廣泛應用。在商業性，各公司正在拓展服務型產品，包括提供包含培訓的檢驗套件、為分散式實驗室提供虛擬支援以及建立物流夥伴關係以確保溫控配送。

競爭優勢取決於創新速度、與診斷平台的有效互通性以及快速擴大生產規模以滿足突發需求的能力。那些能夠保持嚴謹的供應鏈風險管理、積極與監管機構溝通並提供以客戶為中心的技術支援的企業，將贏得臨床檢測採購方的長期信任。

為確保臨床應用和業務永續營運，提出切實可行的建議，以協調產品開發、供應鏈彈性、監管溝通和商業模式。

產業領導者應採取多維度策略，兼顧產品績效、供應鏈韌性、監管合規性和客戶體驗。優先進行設計檢驗，證明其與自動化分析儀和手動工作流程的兼容性，可降低醫院、實驗室和分散式檢查機構的採用門檻。同樣重要的是，要投資收集運輸培養基和收穫成分在實際溫度和運輸條件下的可靠穩定性數據，以最大限度地減少分析前變異性。

為降低貿易和供應風險，製造商和買家應考慮籌資策略多元化，並為特種纖維和聚合物等關鍵零件建立雙重採購安排。在經濟可行的情況下，與本地生產商或區域契約製造製造商合作可以縮短前置作業時間，並降低跨境關稅的影響。商務團隊應為大型醫療保健系統制定靈活的合約方案，將數量承諾與庫存和交付服務水準保證相結合。

在操作層面，擴大照護現場和本地採集的技術支援和培訓可以減少人為錯誤並提高檢體品質。製造商還可以探索附加價值服務，例如提供具有清晰說明的已驗證採集套件、用於監管鏈的數位追蹤以及整合物流解決方案。最後，將永續性目標融入產品設計和包裝，與日益重視環境影響的採購政策相契合，而與監管機構進行積極的溝通則有助於產品在多區域推廣應用。

解釋如何透過結合主要相關人員訪談、實地觀察和二手資料三角驗證來支撐研究結果及其可信度。

本報告的研究結合了結構化的初步研究和嚴謹的二次檢驗，以確保研究結果是基於實證證據和實際操作情況。初步研究包括對臨床實驗室主任、採購負責人、醫院供應鏈經理和產品開發專家的深入訪談，這些訪談提供了關於檢體處理挑戰、驗證預期和採購決策促進因素的第一手資料。對檢體採集工作流程的人類學觀察補充了訪談數據，突顯了照護現場和社區採集點面臨的實際限制。

二次分析參考了同儕審查文獻、監管指導文件以及與檢體採集材料和運輸培養基相關的技術標準。供應鏈圖譜分析識別了與單一來源組件和物流瓶頸相關的薄弱環節，並透過與實驗室性能數據的交叉檢驗，證實了產品設計選擇對實際應用的影響。整個分析過程中均採用了資料三角測量法，以協調不同的觀點，並確保定性見解與已記錄的操作實踐一致。

透過記錄資料納入標準、對訪談主題進行透明編碼，以及在適用情況下與領域專家進行迭代檢驗，確保了分析的嚴謹性。因此，建議策略著重於適應性和對實施情況的短期監測。在所有關鍵環節中，均遵守了有關保密和知情同意的資訊來源標準。

總結產品、供應鏈和監管策略的協調一致對於維持診斷信心和檢體採集營運韌性至關重要的原因。

研究結果共同證明，檢體採集不僅是後勤支援的必要環節，更是提升診斷效能的關鍵策略因素。拭子材料、運輸培養基化學成分和試管設計的進步，以及自動化程度的提高，正在提升分析前檢測的可靠性，並使不同醫療機構的診斷能力得到更廣泛的應用。然而，不斷變化的貿易政策、供應鏈集中度以及區域監管差異，都帶來了特定的營運風險，需要製造商、經銷商和大型機構採購商積極採取措施加以規避。

成功的策略包括：使產品設計與檢驗的臨床工作流程相符；調整籌資策略以降低交易風險；以及使市售產品與醫院、實驗室和分散式檢查機構的採購實際情況相符。那些整合可靠檢驗數據、投資於生產靈活性並提供全面技術支援的機構，最能確保供應的連續性並滿足日益成長的性能期望。未來需要產品開發、法規規劃和供應鏈管理部門協同行動，以確保檢體採集系統能持續支援精準診斷和穩健的醫療服務。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合先進的分子運輸載體，以提高病毒檢體在遠距運輸過程中的穩定性
  • 實施自動化檢體採集和處理流程可降低污染風險並提高細菌診斷的通量。
  • 為了支援分散式檢查，對具有即時去活化功能的照護現場分子病毒採集套件的需求日益成長。
  • 創新常溫病毒運輸培養基配方，消除資源匱乏地區對低溫運輸的依賴
  • 微生物保存系統獲得監管部門核准，以確保檢體在下一代定序應用中的活性

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按檢體類型分類的細菌和病毒檢體採集市場

  • 細菌
    • 血
    • 尿
    • 刮痕
  • 病毒
    • 血
    • 鼻咽拭子
    • 唾液

第9章 細菌和病毒檢體採集市場​​（按產品分類）

  • 收集套件
  • 收集管
    • 非真空管
    • 真空管
  • 拭子
    • 拭子
    • 羊群拭子
    • 泡棉棉籤
  • 運輸介質
    • 細菌轉運培養基
    • 病毒運輸載體

第10章 按技術分類的細菌和病毒檢體採集市場

  • 自動的
  • 手動的

第11章 按最終用戶分類的細菌和病毒檢體採集市場

  • 診所
  • 診斷中心
  • 醫院
  • 研究所

第12章 按分銷管道分類的細菌和病毒檢體採集市場

  • 直銷
  • 經銷商
  • 線上銷售

第13章 各地區細菌和病毒檢體採集市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按組別分類的細菌和病毒檢體採集市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國細菌與病毒檢體採集市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Merck KGaA
    • Roche Holding AG
    • bioMerieux SA
    • QIAGEN NV
    • Copan Diagnostics Inc.
    • Puritan Medical Products Company, LLC
    • Greiner Bio-One International GmbH
Product Code: MRR-FB6C9E792A02

The Bacterial & Viral Specimen Collection Market is projected to grow by USD 50.35 billion at a CAGR of 10.22% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 23.10 billion
Estimated Year [2025] USD 25.45 billion
Forecast Year [2032] USD 50.35 billion
CAGR (%) 10.22%

Understanding how specimen collection quality and operational resilience are becoming central to diagnostic accuracy and public health preparedness in evolving clinical environments

Bacterial and viral specimen collection is a foundational pillar of modern clinical diagnostics, infectious disease surveillance, and therapeutic monitoring. High-integrity specimen collection ensures accurate laboratory results, supports timely clinical decision-making, and underpins public health responses to emerging outbreaks. Over recent years, the interplay between advancing laboratory technologies and evolving clinical workflows has heightened the importance of collection systems that preserve specimen integrity across increasingly decentralized care settings.

As diagnostic modalities have diversified, specimen collection has shifted from a narrow logistics function to a critical component of end-to-end diagnostic quality. Clinical laboratories, hospitals, outpatient clinics, and diagnostic centers demand systems that reliably support molecular assays, culture-based methods, and point-of-care testing. Concurrently, manufacturers and procurement teams face complex requirements around compatibility with automated analyzers, stability of transport media, swab material performance, and cold-chain or ambient-stability constraints.

This introduction situates specimen collection within a broader diagnostic ecosystem that prioritizes sample quality, traceability, and workflow efficiency. The following sections analyze the drivers reshaping product design, supply chains, and regional demand patterns, providing a comprehensive foundation for understanding strategic choices in product development, procurement, and operational resilience.

Examining the converging technological, clinical, and supply chain forces that are redefining specimen collection systems and operational expectations for diagnostics

The landscape for bacterial and viral specimen collection is experiencing transformative shifts driven by technological innovation, regulatory refinement, and evolving care delivery models. Advances in swab materials, transport media formulations, and specimen-compatible collection tubes have created new possibilities for preserving nucleic acids and viable organisms across diverse clinical contexts. These technical developments are complemented by improvements in automation, which streamline workflows in high-throughput laboratories and reduce pre-analytical variability.

Simultaneously, decentralization of testing to point-of-care settings, drive-through collection sites, and at-home sampling has introduced fresh design imperatives: ease of use, sample stability at ambient temperatures, and robust instructions for non-clinical users. The increasing reliance on molecular diagnostics amplifies the need for transport media that prevent nucleic acid degradation and minimize inhibitory contaminants. In response, manufacturers are prioritizing cross-compatibility with diagnostic platforms and validating performance across both traditional clinical matrices and newer self-collected specimens.

On the commercial front, distribution models are shifting as digital procurement channels mature and distributors expand service offerings to include cold-chain logistics and last-mile fulfillment. Environmental sustainability is also emerging as an operational priority, prompting innovation in materials and packaging. Collectively, these forces are redefining product roadmaps, procurement criteria, and quality assurance practices across the specimen collection value chain.

Analyzing how recent tariff policies have reshaped procurement economics, supply chain localization incentives, and supplier strategies for specimen collection components

The introduction of new tariff measures in 2025 targeting certain imported medical goods has created a tangible inflection point for specimen collection supply chains and procurement economics. Tariff-induced cost pressures are most pronounced for components that are heavily sourced internationally, including specialized swab fibers, polymer collection tubes, and niche reagents used in transport media. These incremental costs feed into procurement decisions across hospitals, laboratories, and diagnostic centers, compounding existing pressures on operational budgets and procurement cycles.

In response, stakeholders have pursued multiple adaptation strategies. Some manufacturers accelerated localization of manufacturing capacity to reduce exposure to cross-border levies and to shorten lead times. Others optimized bill-of-materials, substituting raw materials where clinically acceptable and pursuing design efficiencies that lower import dependence. Distributors and direct sales teams recalibrated pricing models and service bundles to preserve margins while maintaining competitive delivery timelines for end users. For clinical laboratories and large hospital systems, procurement teams intensified supplier diversification and long-term contracting to manage price volatility and secure inventory buffers.

Beyond immediate cost impacts, tariffs have affected strategic investment choices. Decisions about capital investment in automation infrastructure, inventory carrying policies, and supplier qualification timelines now incorporate a new layer of trade-policy risk assessment. While these adjustments increase near-term complexity, they have also catalyzed opportunities for domestic suppliers and contract manufacturers to scale capacity and for end users to negotiate integrated service agreements that mitigate total cost impacts across the specimen lifecycle.

Translating specimen type, product architecture, technology platforms, end-user requirements, and distribution pathways into actionable product and commercial priorities

A granular understanding of segmentation is essential to align product design and commercial strategies with clinical needs. Specimen types influence both material selection and logistics: bacterial specimens originating from blood, urine, and wound sources impose different sterility, container, and transport media requirements than viral specimens collected from blood, nasopharyngeal swabs, or saliva. Each specimen matrix presents distinct stability challenges and pre-analytical variables that must be validated against intended diagnostic methods.

Product-level segmentation further delineates performance expectations. Collection kits integrate multiple components to ensure safe, traceable sampling; collection tubes-available in both vacuum and nonvacuum formats-must be compatible with downstream automation and centrifugation workflows. Swab design choices among cotton, flocked, and foam variants affect sample uptake and release kinetics, which in turn influence analytical sensitivity. Transport media formulations bifurcate into bacterial and viral transport media, each optimized to maintain viability or nucleic acid integrity under specified temperature and time windows.

Technology segmentation underscores operational trade-offs: automated systems enhance throughput and reduce pre-analytical errors, while manual approaches retain flexibility for low-volume or decentralized settings. End-user segmentation drives procurement preferences and volume dynamics. Clinics and diagnostic centers often prioritize cost-effective, easy-to-use solutions suited to point-of-care contexts; hospitals demand compatibility with centralized laboratory automation and robust traceability; laboratories value batch processing compatibility, validation data, and supply continuity. Distribution choices-whether direct sales, distributors, or online channels-shape time-to-delivery, service levels, and pricing transparency, and they influence how manufacturers structure commercial partnerships and after-sales support.

Mapping how regional regulatory regimes, manufacturing capacity, and clinical infrastructure are shaping product development priorities and distribution models worldwide

Regional dynamics play a decisive role in how product design, regulatory strategy, and distribution models are prioritized. In the Americas, robust laboratory networks and significant investment in molecular diagnostics create consistent demand for high-performance transport media, swab diversity, and automated-compatible collection tubes. Procurement cycles in large hospital systems are often centralized, enabling volume negotiations but also requiring extensive validation data to secure long-term contracts. Supply chain resilience and domestic manufacturing remain focal areas for policy and private-sector investment in this region.

The Europe, Middle East & Africa region presents a heterogeneous landscape. Regulatory stringency across parts of Europe demands comprehensive technical documentation and conformity assessments, whereas other parts of the region prioritize affordability and ease of use to address wider diagnostic access challenges. Distribution networks vary widely, and success often depends on local partnerships that can manage cold-chain logistics and regulatory submissions. Market entry strategies in this region benefit from adaptable product configurations and regionally tailored training resources.

Asia-Pacific continues to be a growth and innovation hub, with rapid adoption of automation in large centralized laboratories alongside expanding point-of-care and community testing infrastructure. Manufacturing capacity in parts of this region supports global supply chains, while regulatory pathways in several markets have become more streamlined, enabling faster product introductions. Across regions, interoperability with diagnostic platforms, validated stability profiles under local climatic conditions, and culturally appropriate collection instructions are recurring priorities that inform product development and go-to-market approaches.

Identifying strategic moves by leading organizations that combine product innovation, manufacturing agility, and service-enabled commercialization to win in specimen collection

Leading firms and innovative challengers in the specimen collection space are pursuing a set of parallel strategic priorities to capture value across the diagnostic value chain. Vertical integration remains a compelling approach: companies that control upstream raw material sourcing, in-house media formulation, and contracted manufacturing achieve tighter quality control and shorter lead times. Where vertical integration is not feasible, strategic alliances and co-development agreements with reagent and diagnostic platform providers help align compatibility requirements and accelerate validation pathways.

Investment in research and development is concentrated on materials science for swabs, stabilizing chemistries for ambient-temperature transport media, and tube designs that balance automation compatibility with biosafety. Several market participants have prioritized regulatory submissions across multiple geographies, coupling clinical performance data with robust manufacturing quality systems to facilitate broader adoption by hospitals and reference laboratories. Commercially, firms are expanding service-oriented offerings-such as validated kits bundled with training, virtual support for decentralized testing sites, and logistics partnerships to ensure temperature-controlled distribution.

Competitive differentiation increasingly rests on speed of innovation, validated interoperability with diagnostic platforms, and the ability to scale manufacturing rapidly in response to episodic demand. Organizations that maintain disciplined supply chain risk management, proactive regulatory engagement, and customer-centric technical support stand to gain sustained trust among clinical and laboratory buyers.

Actionable recommendations for aligning product development, supply resilience, regulatory engagement, and commercial models to secure clinical adoption and operational continuity

Industry leaders should adopt a multi-dimensional strategy that addresses product performance, supply chain resilience, regulatory alignment, and customer experience. Prioritizing design validation that demonstrates compatibility with both automated analyzers and manual workflows will reduce barriers to adoption across hospitals, laboratories, and decentralized testing sites. Equally important is investing in robust stability data for transport media and collection components under real-world temperature and transit conditions to minimize pre-analytical variability.

To mitigate trade-policy and supply risk, manufacturers and buyers should consider diversifying sourcing strategies and establishing dual-sourcing arrangements for critical components like specialized fibers and polymers. Where economically viable, localizing production or partnering with regional contract manufacturers can shorten lead times and reduce exposure to cross-border tariffs. Commercial teams should structure flexible contracting options for large health systems, combining volume commitments with service-level guarantees for inventory and delivery.

Operationally, expanding technical support and training for point-of-care and community collection reduces user error and improves specimen quality. Manufacturers can also explore value-added services such as validated collection kits that include clear instructions, digital tracking for chain-of-custody, and integrated logistics solutions. Finally, embedding sustainability goals into product design and packaging will resonate with procurement policies that increasingly incorporate environmental impact considerations, while careful engagement with regulatory bodies will expedite multi-region product introductions.

Describing the combination of primary stakeholder interviews, field observations, and secondary data triangulation that underpins the research findings and their reliability

The research underpinning this report combines structured primary investigation with rigorous secondary validation to ensure findings are grounded in empirical evidence and operational realities. Primary inputs included in-depth interviews with clinical laboratory directors, procurement leaders, hospital supply chain managers, and product development specialists, which provided first-hand accounts of specimen handling challenges, validation expectations, and procurement decision drivers. Ethnographic observations of sample collection workflows supplemented interview data to highlight practical constraints faced by point-of-care and community collection settings.

Secondary analysis reviewed peer-reviewed literature, regulatory guidance documents, and technical standards relevant to specimen collection materials and transport media. Supply chain mapping identified vulnerabilities related to single-source components and logistic chokepoints, while cross-validation against laboratory performance data confirmed the real-world implications of product design choices. Data triangulation methods were applied throughout to reconcile differing perspectives and to ensure consistency between qualitative insights and documented operational practices.

Where applicable, analytic rigor was maintained through documented inclusion criteria for sources, transparent coding of interview themes, and iterative validation sessions with subject-matter experts. Limitations include the dynamic nature of trade policy and episodic demand spikes, which can alter operational conditions rapidly; consequently, recommended strategies emphasize adaptability and near-term monitoring of policy developments. Ethical standards for confidentiality and informed consent were upheld across all primary engagements.

Synthesizing why coordinated product, supply chain, and regulatory strategies are essential to sustain diagnostic reliability and operational resilience in specimen collection

The collective findings underscore that specimen collection is a strategic enabler of diagnostic performance, not merely a logistical necessity. Advances in swab materials, transport media chemistry, and tube design, paired with greater automation uptake, are improving pre-analytical reliability and enabling broader diagnostic capability in diverse care settings. However, evolving trade policies, supply chain concentration, and regional regulatory variability create tangible operational risk that demands proactive mitigation by manufacturers, distributors, and large institutional buyers.

Successful strategies converge around alignment: aligning product designs to validated clinical workflows, aligning sourcing strategies to reduce trade exposure, and aligning commercial offerings to the procurement realities of hospitals, laboratories, and decentralized testing sites. Organizations that integrate robust validation data, invest in manufacturing flexibility, and provide comprehensive technical support will be best positioned to maintain continuity of supply and to meet heightened performance expectations. The path forward calls for coordinated action across product development, regulatory planning, and supply chain management to ensure specimen collection systems continue to support accurate diagnostics and resilient healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of advanced molecular transport media for enhanced viral specimen stability during long distance shipments
  • 5.2. Adoption of automated specimen collection and processing workflows to reduce contamination risk and increase throughput for bacterial diagnostics
  • 5.3. Rising demand for point-of-care molecular viral collection kits with immediate inactivation to support decentralized testing
  • 5.4. Innovations in ambient temperature viral transport media formulations to eliminate cold chain dependence in low-resource settings
  • 5.5. Regulatory approval of microbial preservation systems ensuring specimen viability for next-generation sequencing applications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bacterial & Viral Specimen Collection Market, by Specimen Type

  • 8.1. Bacterial
    • 8.1.1. Blood
    • 8.1.2. Urine
    • 8.1.3. Wound
  • 8.2. Viral
    • 8.2.1. Blood
    • 8.2.2. Nasopharyngeal Swab
    • 8.2.3. Saliva

9. Bacterial & Viral Specimen Collection Market, by Product

  • 9.1. Collection Kit
  • 9.2. Collection Tube
    • 9.2.1. Nonvacuum Tube
    • 9.2.2. Vacuum Tube
  • 9.3. Swab
    • 9.3.1. Cotton Swab
    • 9.3.2. Flocked Swab
    • 9.3.3. Foam Swab
  • 9.4. Transport Media
    • 9.4.1. Bacterial Transport Media
    • 9.4.2. Viral Transport Media

10. Bacterial & Viral Specimen Collection Market, by Technology

  • 10.1. Automated
  • 10.2. Manual

11. Bacterial & Viral Specimen Collection Market, by End User

  • 11.1. Clinics
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Laboratories

12. Bacterial & Viral Specimen Collection Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Sales

13. Bacterial & Viral Specimen Collection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bacterial & Viral Specimen Collection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bacterial & Viral Specimen Collection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Danaher Corporation
    • 16.3.4. Merck KGaA
    • 16.3.5. Roche Holding AG
    • 16.3.6. bioMerieux SA
    • 16.3.7. QIAGEN N.V.
    • 16.3.8. Copan Diagnostics Inc.
    • 16.3.9. Puritan Medical Products Company, LLC
    • 16.3.10. Greiner Bio-One International GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY WOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION KIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NONVACUUM TUBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL TRANSPORT MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRAL, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TUBE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWAB, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIA, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA BACTERIAL &